Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma

B. Schermers* (Corresponding Author), V. Franke, E. A. Rozeman, B.A. van de Wiel, A. Bruining, M.W. Wouters, W.J. van Houdt, B. ten Haken, S.H. Muller, C. Bierman, T.J.M. Ruers, C.U. Blank, A.C.J. van Akkooi

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)
40 Downloads (Pure)

Abstract

This pilot study explored the value of localized index node removal after neoadjuvant immunotherapy in patients with stage III melanoma, for use as a response indicator to guide the extent of completion lymph node dissection.
Original languageEnglish
Pages (from-to)519-522
Number of pages4
JournalBritish journal of surgery
Volume106
Issue number5
DOIs
Publication statusPublished - 1 Apr 2019

Keywords

  • UT-Hybrid-D

Fingerprint

Dive into the research topics of 'Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma'. Together they form a unique fingerprint.

Cite this